The IFCC Emerging Technologies Division (ETD) is a new Division proposed and formally ratified by the IFCC Executive Board in 2017. The ETD formally takes effect from 1st January 2018.
Two Task Forces previously under the Executive Committee umbrella (Task Force on Paediatric Laboratory Medicine (TF-PLM) and the Task Force on Geriatric Laboratory Medicine (TF-GLM)) are now part of the ETD.
The ETD is a functional unit responsible for identifying and assessing emerging technologies and for translating the emerging and disruptive diagnostic and data analysis procedures from academic laboratories to clinical laboratories and from clinical laboratories to market.
The ETD initiates and manages projects through its Committees and Working Groups (WG). Work is conducted in strict cooperation with other IFCC units and with relevant national and international organisations. The ETD ensures that each of its Committees and Working Groups are functioning under clear terms of reference together with an agreed upon schedule of activity. The ETD will assist in the development of project proposals and will undertake an annual review of progress and review as well as approve documents arising from such projects.
The ETD is a functional unit of the IFCC involved in the production of publications arising from activities relating to the application of emerging and disruptive technologies to clinical laboratories.
All ETD activities are well-defined projects, which work within a specified time frame, and are intended to result in a document (an IFCC official document or manual, guideline, or a scientific paper in a refereed international journal), in a product (reference system, service or device), or within the framework of an international activity (scientific workshop, symposium or congress).
The ETD is responsible to the EB and Council to ensure the highest standards of work in its units and for the actions of its members.
The ETD initiates and manages projects with its own resources or through its Committees and Working Groups. Work is conducted in cooperation with other IFCC units and with relevant national and international organizations. The ETD ensures that each of its Committees and WGs are functioning under clear terms of reference together with an agreed upon schedule of activity. The ETD-EC will assist in the development of the project proposals, and will undertake an annual review of progress as well as review and approve any documents that result from the work. Project applications should be made on the ETD Project Proposal Form (available here).
At the time of publication of this webpage, the proposed ETD Committees have not been formally ratified by the IFCC Executive Board and are therefore not listed yet.
At the time of publication of this webpage, the proposed ETD Working groups have not been formally ratified by the IFCC Executive Board and are therefore not listed yet.
The Corporate Members bring relevant industry expertise, experience and support to the Division to facilitate more involvement, voice, support from IFCC industry members and help drive Executive Committee’s missions and projects. IFCC Corporate Members may propose projects.
|Name||Position||Country||Term||Time in Office|
|S. Bernardini||Chair||IT||1st||2018 01 - 2020 12|
|P. Fortina||Vice-Chair||US||1st||2018 01 - 2020 12|
|R. Greaves||Secretary||AU||1st||2018 01 - 2020 12|
|D. Gruson||Member||BE||1st||2018 01 - 2020 12|
|M. Roessler||Corporate Member||DE||1st||2018 01 - 2020 12|
|P. Yin||Corporate Member||US||1st||2018 01 - 2020 12|
Prof. Sergio BERNARDINI
Prof. Paolo FORTINA
A/Prof Ronda GREAVES
Prof Damien GRUSON
Dr Markus ROESSLER
Dr Peng YIN
|Dr Larry KRICKA
Department of Pathology & Lab. Medicine
University of Pennsylvania Medical Center
3400 Spruce Street
Philadelphia, PA 19104 - USA